Clinical Trial

A Drug-Drug Interaction Study of Denifanstat and Resmetirom in Healthy Adult Participants

Completed Phase 1
View on ClinicalTrials.gov →
Summary
This is an open-label, 2-cohort study to evaluate the mutual DDI potential between denifanstat and resmetirom in healthy adult participants.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-10-10; most recent amendment 2026-01-21.
Status change: Active, Not Recruiting → Completed 2026-01-21
Status change: Recruiting → Active, Not Recruiting 2025-10-14
Trial Details
NCT Number NCT07216313
Lead Sponsor Sagimet Biosciences Inc.
Conditions Healthy
Enrollment 40 participants
Start Date 2025-09-30
Primary Completion 2025-10-20 (estimated)
Study Completion 2025-10-20 (estimated)
Updated on ClinicalTrials.gov 2026-01-23